Cargando…
Preoperative Chemoradiotherapy plus Nivolumab before Surgery in Patients with Microsatellite Stable and Microsatellite Instability–High Locally Advanced Rectal Cancer
PURPOSE: Preoperative chemoradiotherapy (CRT) and surgical resection are the standard treatment for locally advanced rectal cancer (LARC). Combining immune checkpoint inhibitors with radiation suggests a promising approach for enhancing efficacy. We investigated the efficacy of CRT followed by nivol...
Autores principales: | Bando, Hideaki, Tsukada, Yuichiro, Inamori, Koji, Togashi, Yosuke, Koyama, Shohei, Kotani, Daisuke, Fukuoka, Shota, Yuki, Satoshi, Komatsu, Yoshito, Homma, Shigenori, Taketomi, Akinobu, Uemura, Mamoru, Kato, Takeshi, Fukui, Makoto, Wakabayashi, Masashi, Nakamura, Naoki, Kojima, Motohiro, Kawachi, Hiroshi, Kirsch, Richard, Yoshida, Tsutomu, Suzuki, Yutaka, Sato, Akihiro, Nishikawa, Hiroyoshi, Ito, Masaaki, Yoshino, Takayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365382/ https://www.ncbi.nlm.nih.gov/pubmed/35063964 http://dx.doi.org/10.1158/1078-0432.CCR-21-3213 |
Ejemplares similares
-
IMMU-26. DISEASE CONTROL IN A PEDIATRIC PATIENT WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) AND SOMATIC HIGH MICROSATELLITE INSTABILITY (MSI-H) WITH PD-1 INHIBITOR NIVOLUMAB (NIVO) ONLY AND NO FOCAL RADIOTHERAPY (RT)
por: Larkin, Trisha, et al.
Publicado: (2020) -
Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer
por: Akce, Mehmet, et al.
Publicado: (2023) -
Plasma-based microsatellite instability detection strategy to guide immune checkpoint blockade treatment
por: Wang, Zhenghang, et al.
Publicado: (2020) -
P060: Prognosis of patients with relapsed and refractory classic Hodgkin lymphoma after nivolumab discontinuation and efficacy of nivolumab retreatment
por: Fedorova, Liudmila, et al.
Publicado: (2022) -
IMMU-09. NIVOLUMAB THERAPY FOR A PEDIATRIC-ONSET PRIMARY INTRACRANIAL MELANOMA
por: Oba, Utako, et al.
Publicado: (2020)